BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, ...
Sernova Biotherapeutics and Germantown, Maryland-based Seraxis announced on October 5, 2026 the closing of a US10 million ...
CHOP marks a new chapter as Bell retires after nearly 40 years and Mitchell takes the helm. Children’s Hospital of ...
The 2026 Philadelphia ORBIE Awards, presented by PhillyCIO and PhillyCISO, part of the Inspire Leadership Network, honored ...
Degrees Pharmaceuticals, a Washington, D.C.-based company developing medicines for vector-borne disease, announced on October ...
Gilead’s $7.8 billion buyout of Arcellx closed in April. The more durable return may be the operators that deal released into ...
Secretome Therapeutics, a clinical-stage biotechnology company developing therapies derived from neonatal cardiac progenitor ...
Chilipad, the North Carolina sleep technology company behind the water-based Chilipad 2.0 cooling system, has launched a year ...
Treg Therapeutics, a biotech developing therapies designed to restore immune tolerance, has announced a partnership with Eva ...
SereNeuro Therapeutics, a preclinical-stage biotechnology company developing non-opioid therapies for pain, has announced ...
CorestemChemon, a biopharmaceutical company headquartered in South Korea, has begun U.S. operations based in Winston-Salem’s ...
Pace Life Sciences, the life sciences division of science and technology company Pace, has named Andrew (Andy) Fenny as its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results